We provide contract metabolic activity and toxicity services using our proprietary autobioluminescent technology.
We are proud to serve as the industry’s premier provider of continuous, real-time, bioluminescent metabolic activity tracking assays.
These assays, which continuously and non-invasively track the metabolic dynamics of relevant cell types over prolonged exposure periods to identify the metabolic and cytotoxic effects of compounds both pre- and post-metabolism, are ideally suited to rapidly and cost effectively position novel compound candidates for down-pipeline success.
Contact us today to learn how our real-time bioluminescent monitoring approach can provide you with the pre-clinical development data you need to make more informed candidate selection decisions. Our approach provides an inexpensive alternative to in-house endpoint screens or costly out-sourcing alternatives so you can focus your time and resources on developing your next breakthrough candidate.